Vito Borzı̀

753 total citations
20 papers, 537 citations indexed

About

Vito Borzı̀ is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Genetics. According to data from OpenAlex, Vito Borzı̀ has authored 20 papers receiving a total of 537 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Endocrinology, Diabetes and Metabolism, 5 papers in Molecular Biology and 5 papers in Genetics. Recurrent topics in Vito Borzı̀'s work include Diabetes Management and Research (12 papers), Diabetes Treatment and Management (9 papers) and Hyperglycemia and glycemic control in critically ill and hospitalized patients (7 papers). Vito Borzı̀ is often cited by papers focused on Diabetes Management and Research (12 papers), Diabetes Treatment and Management (9 papers) and Hyperglycemia and glycemic control in critically ill and hospitalized patients (7 papers). Vito Borzı̀ collaborates with scholars based in Italy, France and Japan. Vito Borzı̀'s co-authors include Ryuzo Kawamori, P. Valensi, Janusz Gumprecht, Robert J. Ligthelm, Yang Wen-ying, Marian Benroubi, Francesco Belfiore, Wenying Yang, М. В. Шестакова and Jakub Gumprecht and has published in prestigious journals such as SHILAP Revista de lepidopterología, Diabetes Care and Diabetes.

In The Last Decade

Vito Borzı̀

19 papers receiving 511 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Vito Borzı̀ Italy 12 365 91 81 74 61 20 537
Paola Ponzani Italy 13 312 0.9× 82 0.9× 64 0.8× 30 0.4× 164 2.7× 35 503
Rachid Malek Algeria 11 375 1.0× 46 0.5× 68 0.8× 147 2.0× 60 1.0× 50 583
Andreas Liebl Germany 10 426 1.2× 33 0.4× 93 1.1× 55 0.7× 121 2.0× 17 509
Stanley Feld United States 5 451 1.2× 74 0.8× 99 1.2× 45 0.6× 89 1.5× 8 518
Margaret Tiktin United States 6 336 0.9× 37 0.4× 64 0.8× 52 0.7× 86 1.4× 7 480
B Y Tan Singapore 8 246 0.7× 38 0.4× 52 0.6× 57 0.8× 65 1.1× 9 414
Marsha Harris United States 4 291 0.8× 82 0.9× 60 0.7× 39 0.5× 84 1.4× 4 452
Oliver Schnell Germany 11 403 1.1× 75 0.8× 101 1.2× 55 0.7× 106 1.7× 18 546
K. Jameson United Kingdom 9 463 1.3× 88 1.0× 147 1.8× 54 0.7× 93 1.5× 14 613
Shehla Shaikh India 11 301 0.8× 63 0.7× 176 2.2× 202 2.7× 63 1.0× 37 548

Countries citing papers authored by Vito Borzı̀

Since Specialization
Citations

This map shows the geographic impact of Vito Borzı̀'s research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vito Borzı̀ with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vito Borzı̀ more than expected).

Fields of papers citing papers by Vito Borzı̀

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vito Borzı̀. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vito Borzı̀. The network helps show where Vito Borzı̀ may publish in the future.

Co-authorship network of co-authors of Vito Borzı̀

This figure shows the co-authorship network connecting the top 25 collaborators of Vito Borzı̀. A scholar is included among the top collaborators of Vito Borzı̀ based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vito Borzı̀. Vito Borzı̀ is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Borzı̀, Vito, Stefania Frasson, Gualberto Gussoni, et al.. (2016). Risk factors for hypoglycemia in patients with type 2 diabetes, hospitalized in internal medicine wards: Findings from the FADOI-DIAMOND study. Diabetes Research and Clinical Practice. 115. 24–30. 30 indexed citations
2.
Borzı̀, Vito & Andrea Fontanella. (2015). The clinical impact of hypoglycemia in hospitalized patients. SHILAP Revista de lepidopterología. 9(1). 11–11. 5 indexed citations
3.
Gulli, Giovanni, Stefania Frasson, Vito Borzı̀, et al.. (2014). Effectiveness of an educational intervention on the management of type 2 diabetic patients hospitalized in Internal Medicine: results from the FADOI-DIAMOND study. Acta Diabetologica. 51(5). 765–770. 11 indexed citations
4.
Valensi, P., Marian Benroubi, Ryuzo Kawamori, et al.. (2013). Predictors of achieving HbA1c <7% and no hypoglycaemia 6 months after initiation of biphasic insulin aspart 30 in patients with type 2 diabetes in the IMPROVE study. Current Medical Research and Opinion. 29(6). 601–609. 8 indexed citations
5.
Borzı̀, Vito, Marian Benroubi, Janusz Gumprecht, et al.. (2012). Predictors of postprandial blood glucose response to biphasic insulin analogue therapy. Primary care diabetes. 7(1). 63–67. 1 indexed citations
6.
Giorda, Carlo, et al.. (2010). The IMPROVE study--a multinational, multicentre, observational study in type 2 diabetes: results from the Italian cohort.. PubMed. 81(2). 115–24. 4 indexed citations
7.
Gumprecht, Janusz, Marian Benroubi, Vito Borzı̀, et al.. (2009). Intensification to biphasic insulin aspart 30/70 (BIAsp 30, NovoMix®30) can improve glycaemic control in patients treated with basal insulins: a subgroup analysis of the IMPROVE™observational study. International Journal of Clinical Practice. 63(6). 966–972. 39 indexed citations
8.
9.
Benroubi, Marian, Vito Borzı̀, Jakub Gumprecht, et al.. (2009). Safety and effectiveness of biphasic insulin aspart 30/70 (NovoMix®30) when switching from human premix insulin in patients with type 2 diabetes: subgroup analysis from the 6-month IMPROVE™ observational study. International Journal of Clinical Practice. 63(4). 574–582. 36 indexed citations
10.
Yang, Wenying, Marian Benroubi, Vito Borzı̀, et al.. (2009). Improved glycaemic control with BIAsp 30 in insulin-naïve type 2 diabetes patients inadequately controlled on oral antidiabetics: subgroup analysis from the IMPROVE study. Current Medical Research and Opinion. 25(11). 2643–2654. 11 indexed citations
11.
Valensi, P., Marian Benroubi, Vito Borzı̀, et al.. (2008). The IMPROVE™ study - a multinational, observational study in type 2 diabetes: baseline characteristics from eight national cohorts. International Journal of Clinical Practice. 62(11). 1809–1819. 78 indexed citations
12.
Ligthelm, Robert J., Vito Borzı̀, Janusz Gumprecht, et al.. (2007). Importance of Observational Studies in Clinical Practice. Clinical Therapeutics. 29(6). 1284–1292. 138 indexed citations
13.
Signorelli, Salvatore Santo, Salvatore Sciacchitano, Vito Borzı̀, et al.. (2004). Correlation between some metabolic markers of vascular risk and carotid artery intima-media thickness in postmenopausal women. Maturitas. 49(2). 134–139.
14.
Trischitta, Vincenzo, et al.. (1989). Low-Dose Bedtime NPH Insulin in Treatment of Secondary Failure to Glyburide. Diabetes Care. 12(8). 582–585. 21 indexed citations
15.
Belfiore, Francesco, et al.. (1976). Enzymes related to lipogenesis in the adipose tissue of obese subjects. Metabolism. 25(5). 483–493. 14 indexed citations
16.
Belfiore, Francesco, et al.. (1976). NADPH-forming dehydrogenases in the adipose tissue of obese and nonobese diabetics. Metabolism. 25(7). 723–725. 2 indexed citations
17.
Belfiore, Francesco, et al.. (1975). Enzyme Activities of NADPH-Forming Metabolic Pathways in Normal and Leukemic Leukocytes. Clinical Chemistry. 21(7). 880–883. 4 indexed citations
18.
Belfiore, Francesco, et al.. (1975). Enzymes of Glucose Metabolism and of the Citrate Cleavage Pathway in Adipose Tissue of Normal and Diabetic Subjects. Diabetes. 24(10). 865–873. 17 indexed citations
19.
Belfiore, Francesco, et al.. (1974). Increased β-N-Acetyl-Glucosaminidase Activity in Diabetes Mellitus. Clinical Chemistry. 20(9). 1229–1230. 27 indexed citations
20.
Belfiore, Francesco, et al.. (1974). Increased beta-N-acetyl-glucosaminidase activity in diabetes mellitus.. PubMed. 20(9). 1229–30. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Paola Ponzani Breakdown of academic impact, for papers by Rachid Malek Breakdown of academic impact, for papers by Andreas Liebl Breakdown of academic impact, for papers by Stanley Feld Breakdown of academic impact, for papers by Margaret Tiktin Breakdown of academic impact, for papers by B Y Tan Breakdown of academic impact, for papers by Marsha Harris Breakdown of academic impact, for papers by Oliver Schnell Breakdown of academic impact, for papers by K. Jameson Breakdown of academic impact, for papers by Shehla Shaikh
Rankless by CCL
2026